Introduction
============

The rapidly increasing incidence of obesity is emerging as a worldwide public health problem. As the prevalence of obesity continues to increase, the incidence of diabetes is propelled to upsurge ([@ref-39]; [@ref-17]). The rate of attribution of type 2 diabetes (T2D) to obesity is approximately 90% ([@ref-19]). Bariatric surgery, including gastric bypass (GB) and sleeve gastrectomy (SG), is known as the most effective method of improving obesity, and it is a potential strategy for remission of T2D ([@ref-33]). The promising postsurgical weight loss and the maintenance of weight loss might be a result of modified eating behavior ([@ref-31]; [@ref-23]) or it may be directly due to the surgical procedure ([@ref-32]). GB and SG have been shown to effectively increase satiety sensation ([@ref-38]). Good control of satiety might be related to the attenuation of insulin response ([@ref-36]), while intranasal insulin has been shown to reduce the stimulation of brain activity caused by pictures of food ([@ref-13]). In addition, intracerebroventricular administration of insulin significantly inhibited food intake and functions as an appetite-suppressive peptide ([@ref-11]). Bariatric surgery has been demonstrated to reduce C-peptide levels and improve insulin resistance ([@ref-28]). The improvement of diabetes after bariatric surgery is due to the up-regulation of the insulin signaling pathway ([@ref-3]).

C-peptide, a 31 amino-acid polypeptide, is considered to be a marker for pancreatic insulin secretion ([@ref-4]; [@ref-18]). Our previous studies proposed a diabetes surgery score, the ABCD score (age, body mass index, C-peptide and duration of T2D), which is a clinically applicable parameters used to predict the success of bariatric surgery in obese patients with T2D ([@ref-28]; [@ref-25]). Diabetic patients with higher ABCD score before surgery had a higher rate of T2D remission ([@ref-28]; [@ref-25]). However, the relationships between ABCD score with consumption behaviors and appetite sensations after bariatric surgery are still unknown. In this study, we used the mixed meal tolerance test (MMTT) to investigate the changes in consumption behaviors and appetite sensations, and we correlated these alterations with age, body mass index, C-peptide, and duration of T2D one year after bariatric surgery.

Methods
=======

Patients and metabolic surgery
------------------------------

The patients were enrolled in a previous randomized trial, which included 32 eligible patients with T2D (laparoscopic mini-gastric bypass (GB), *N* = 16; SG, *N* = 16). The GB ([@ref-27]) and SG surgery ([@ref-27]) were performed as previously described. One year after bariatric surgery, all 32 patients agreed to undergo the MMTT. Informed consent was obtained before the study.

This study was conducted at the Department of Surgery of Min-Sheng General Hospital and at Taipei Veterans General Hospital, and was approved by the Ethics Committee of each hospital (the approval number: 201002056IC and 201002037IC).

Surgical technique
------------------

GB was performed as described in our previous studies ([@ref-27]; [@ref-26]). In brief, we used a standard 5-port laparoscopic technique to create a long-sleeve gastric tube by using the EndoGIA stapler (EndoGIA; Coviden, Norvalk, CT, USA); it was approximately 2.0 cm wide along with the lesser curvature from the antrum to the angle of His. We also use an EndoGIA stapler to create a Billroth II type loop gastroenterostomy with the small bowel about 120 cm distal to the ligament of Treitz. There was no drain tube left in place. By using the mesh plug technique with bio-absorbable hemostatic gauze (Cellulostat; Horng Tzer Medical Instruments, Kaohsiung, Taiwan) ([@ref-12]), we closed all the trocar wounds.

For SG, we used a laparoscopic stapler (EndoGIA; Coviden, Norvalk, Connecticut) with 60-cm cartridges (3.5 mm stapler height, blue load) to resect the greater curvature from the distal antrum (4 cm proximal to the pylorus) to the angle of His, including the complete fundus ([@ref-27]). We left the remnant stomach tube, which was approximately 2 cm wide along the less curved side. The extended periumbilical trocar site was used for the extraction of the resected stomach portion.

Mixed meal tolerance test
-------------------------

To compare the consumption behavior and appetite sensations among patients with T2D after metabolic surgery, we used an MMTT. After an overnight fast, patients ate ensure plus (4 oz; 175 kcal; 6.5 g protein; 5.5 g fat; 25 g carbohydrate; Abbott Nutrition, Zwolle, Netherlands) ([@ref-26]). The volume consumed was recorded and the consumed energy was calculated based on the volume of the MMTT after digestion.

Questionnaire on hunger, fullness, desire to eat, satiation, and prospective consumption
----------------------------------------------------------------------------------------

A visual analogue scale (VAS) of 100-mm lines was designed for patients to score their appetite sensations after a test meal with good reliability and validity ([@ref-29]). Similar to our previous study ([@ref-10]; [@ref-40]), the participants were familiarized with assessing the VAS and scoring their appetite sensations, such as hunger, fullness, desire to eat, satiation, and prospective consumption before food intake (0 min) and at 30, 60, 90, 120, 150 and 180 min after a mixed meal. The area under the curve (AUC) and the incremental or decremental area under the curve (ΔAUC) of various appetite VAS scores during the MMTT were measured by the trapezoidal method ([@ref-15]; [@ref-26]). The VAS score for peak-0′ was calculated by subtracting the score at 0 min (before food intake) from the highest score recorded during the MMTT. The VAS score for peak-nadir was calculated by subtracting the lowest score from the highest score recorded during the MMTT.

Statistical analysis
====================

All statistical analyses were performed using the Statistical Package for Social Sciences, version 12.01 (SPSS, Inc., Chicago, IL, USA). Continuous variables were expressed as the mean ± SD. The chi-square test or Fisher's exact test was used to compare categorical variables, while the Mann--Whitney *U* test was used to compare continuous variables. The Wilcoxon signed-rank test was used to compare between baseline and post-operative variables. Friedman's one-way analysis of variance followed by a *post hoc* test was used to analyze the differences among VAS scores for different appetite sensations at 0, 30, 60, 90, 120, 150, and 180 min after intake of a mixed meal. Correlations between the two groups were examined using Spearman's correlation method. A *P* value less than 0.05 was considered statistically significant.

Results
=======

Treatment effect one year after bariatric surgery
-------------------------------------------------

In total, 16 patients undergoing GB and 16 patients undergoing SG were enrolled. Before surgery, there are no static significant differences between GB and SG in age, BMI, C-peptide, the duration of T2D, and homeostasis model assessment-insulin resistance (HOMA-IR) ([Table 1](#table-1){ref-type="table"}). One year after bariatric surgery, the BMI in the GB and SG groups were 22.6 ± 2.5 and 24.4 ± 2.5 kg/m^2^ (*P* \< 0.05), respectively, which was the only statistically significant difference between the two groups. Although the BMI was lower in patients after GB than those after SG, but the ratio of BMI after/before either GB or SG had no significant difference (*P* \> 0.05). Post-operative levels of C-peptide and HOMA-IR were comparable between the GB and SG groups one year after surgery ([Table 1](#table-1){ref-type="table"}).
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###### ABCD scale (age, body mass index, C-peptide, and duration of T2D) before and 1 year after bariatric surgery.

![](peerj-05-3090-g009)

                                      GB (*n* = 16)   SG (*n* = 16)   *P* value
  ----------------------------------- --------------- --------------- -----------
  Age before surgery                  44.3 ± 8.6      46.3 ± 8.0      NS
  BMI before surgery                  29.1 ± 3.1      31.0 ± 2.9      NS
  BMI one year after surgery          22.6 ± 2.5      24.4 ± 2.5      \<0.05
  Ratio of BMI after/before surgery   0.78            0.79            NS
  C-peptide before surgery            2.5 ± 1.1       3.3 ± 1.4       NS
  C-peptide one year after surgery    1.6 ± 1.1       1.7 ± 0.5       NS
  Duration of T2D before surgery      6.0 ± 5.5       6.9 ± 5.4       NS
  HOMA-IR before surgery              9.3 ± 23.2      8.5 ± 6.5       NS
  HOMA-IR one year after surgery      1.2 ± 1.2       2.4 ± 3.5       NS

**Notes.**

Data is expressed as the mean ± SD.

BMIbody mass indexHOMA-IRhomeostasis model assessment-insulin resistanceGBgastric bypassSGsleeve gastrectomyT2Dtype 2 diabetes

The volume, energy, and time of consumption after bariatric surgery
-------------------------------------------------------------------

One year after surgery, there were no significant differences in the volume of consumption between the GB and SG groups (256.6 ± 142.3 mL vs. 231.8 ± 140.3 mL, *P* \> 0.05; [Fig. 1A](#fig-1){ref-type="fig"}). The total energy consumed in the GB and SG groups was comparable (513.1 ± 284.6 Kcal vs. 463.5 ± 280.5 Kcal, *P* \> 0.05; [Fig. 1B](#fig-1){ref-type="fig"}). The time of consumption in the GB had a decreasing trend compared to that in SG (5.7 ± 4.6 min vs. 13.3 ± 23.3 min, *P* \> 0.05; [Fig. 1C](#fig-1){ref-type="fig"}).

![The volume of food consumed (A), energy consumed (B), and consumption time (C) during a mixed meal tolerance test in gastric bypass (*n* = 16) and sleeve gastrectomy (*n* = 16) patients one year after surgery.\
Data is expressed as the mean ± SD.](peerj-05-3090-g001){#fig-1}

Hunger sensation during the MMTT after bariatric surgery
--------------------------------------------------------

The VAS score of hunger sensation in the GB group, but not in the SG group, at 30 min was significantly lower than that at 0 min in the MMTT (*P* \< 0.05; [Fig. 2A](#fig-2){ref-type="fig"}). The scores for hunger sensation in the SG group at 30 and 60 min were significantly lower than that at 180 min (*P* \< 0.05 and 0.05; [Fig. 2A](#fig-2){ref-type="fig"}). No significant difference was found between the GB and SG groups for the AUC~0′--180′~ of the hunger score, the ΔAUC~0′--180′~ of the hunger score, the hunger score for ~peak-0′~ or the hunger score for ~peak-nadir~ ([Figs. 2B](#fig-2){ref-type="fig"}--[2E](#fig-2){ref-type="fig"}).

![The visual analogue scale scores of hunger sensation in gastric bypass and sleeve gastrectomy patients at 0, 30, 60, 90, 120, 150 and 180 min (A), as well as the AUC~0′--180′~ of the hunger rating (B), the ΔAUC~0′--180′~ of the hunger rating (C), the hunger rating ~peak-0′~ (D), and the hunger rating ~peak-nadir~ (E) in a mixed meal tolerance test.\
\# *P* \< 0.05 compared to 0 min, §*P* \< 0.05 compared to 180 min.](peerj-05-3090-g002){#fig-2}

Fullness sensation in MMTT after bariatric surgery
--------------------------------------------------

The VAS score of postoperative fasting fullness sensation was significantly higher in the GB group than in the SG group (*P* \< 0.01; [Fig. 3A](#fig-3){ref-type="fig"}). The score for fullness sensation in the GB group at 30 min was significantly higher than that at 120, 150, and 180 min in the MMTT (*P* \< 0.05; [Fig. 3A](#fig-3){ref-type="fig"}). No significant difference was found between the GB and SG groups in either the AUC~0′--180′~ of the fullness rating, the ΔAUC~0′--180′~ of the fullness rating, the fullness score for ~peak-0′~ or the fullness score for ~peak-nadir~ ([Figs. 3B](#fig-3){ref-type="fig"}--[3E](#fig-3){ref-type="fig"}).

![The visual analogue scale scores of fullness sensation in gastric bypass and sleeve gastrectomy patients at 0, 30, 60, 90, 120, 150 and 180 min (A), as well as the AUC~0′--180′~ of the fullness rating (B), the ΔAUC~0′--180′~ of the fullness rating (C), the fullness rating ~peak-0′~ (D), and the fullness rating ~peak-nadir~ (E) in a mixed meal tolerance test.\
\*\* *P* \< 0.01 compared between gastric bypass and sleeve gastrectomy groups, § *P* \< 0.05 compared to 120, 150, and 180 min.](peerj-05-3090-g003){#fig-3}

Desire to eat sensation in the MMTT after bariatric surgery
-----------------------------------------------------------

The VAS scores for postoperative desire to eat were significantly higher in the GB group than in the SG group at 0, 30, and 60 min (*P* \< 0.05; [Fig. 4A](#fig-4){ref-type="fig"}). The scores for desire to eat in the GB group at 30 and 60 min were significantly lower than that at 0 and 180 min during the MMTT (*P* \< 0.05; [Fig. 4A](#fig-4){ref-type="fig"}). The scores for desire to eat in the SG group at 30, 60, and 90 min were significantly lower than that at 180 min during the MMTT (*P* \< 0.05; [Fig. 4A](#fig-4){ref-type="fig"}). The AUC~0′--180′~ of the desire to eat was higher in the GB group than in the SG group (*P* \< 0.05; [Fig. 4B](#fig-4){ref-type="fig"}). No significant differences were observed between the GB and SG groups in either the ΔAUC~0′--180′~ of the desire to eat rating, the desire to eat rating for ~peak-0′~, or the desire to eat rating for ~peak-nadir~ ([Figs. 4C](#fig-4){ref-type="fig"}--[4E](#fig-4){ref-type="fig"}).

![The visual analogue scale scores of desire to eat in gastric bypass and sleeve gastrectomy patients at 0, 30, 60, 90, 120, 150 and 180 min (A), as well as the AUC~0′--180′~ of the desire to eat (B), the ΔAUC~0′--180′~ of the desire to eat (C), the desire to eat~peak-0′~ (D) and the desire to eat ~peak-nadir~ (E) in a mixed meal tolerance test.\
\* *P* \< 0.05 compared between gastric bypass and sleeve gastrectomy groups, \# *P* \< 0.05 compared to 0 min, §*P* \< 0.05 compared to 180 min.](peerj-05-3090-g004){#fig-4}

Satiation sensation during the MMTT after bariatric surgery
-----------------------------------------------------------

The VAS score for satiation sensation in the GB group at 30 min was significantly higher than that at 150 and 180 min during the MMTT (*P* \< 0.05; [Fig. 5A](#fig-5){ref-type="fig"}). The VAS score for satiation in the SG at 30 min was significantly higher than that at 0 min during the MMTT (*P* \< 0.05; [Fig. 5A](#fig-5){ref-type="fig"}). No significant difference was observed between the GB and SG groups for either the AUC~0′--180′~ of satiation, the ΔAUC~0′--180′~ of satiation, the satiation score for ~peak-0′~ or the satiation score for ~peak-nadir~ ([Figs. 5B](#fig-5){ref-type="fig"}--[5E](#fig-5){ref-type="fig"}).

![The visual analogue scale scores of satiation in gastric bypass and sleeve gastrectomy patients at 0, 30, 60, 90, 120, 150 and 180 min (A), as well as the AUC~0′--180′~ of satiation (B), the ΔAUC~0′--180′~ of satiation (C), the satiation ~peak-0′~ (D), and the satiation ~peak-nadir~ (E) in a mixed meal tolerance test.\
\# *P* \< 0.05 compared to 0 min, § *P* \< 0.05 compared to 150 and 180 min.](peerj-05-3090-g005){#fig-5}

Prospective consumption sensations during the MMTT after bariatric surgery
--------------------------------------------------------------------------

The VAS scores of prospective consumption in the GB group at 30, 60, and 90 min were significantly lower than that at 180 min during the MMTT (*P* \< 0.05; [Fig. 6A](#fig-6){ref-type="fig"}); a similar trend was observed for the SG group (*P* \< 0.05; [Fig. 6A](#fig-6){ref-type="fig"}). No significant difference was observed between the GB and SG groups in either the AUC~0′--180′~ of prospective consumption, the ΔAUC~0′--180′~ of prospective consumption, the prospective consumption score for ~peak-0′~, or the prospective consumption score for ~peak-nadir~ ([Figs. 6B](#fig-6){ref-type="fig"}--[6E](#fig-6){ref-type="fig"}).

![The visual analogue scale scores of prospective consumption in gastric bypass and sleeve gastrectomy patients at 0, 30, 60, 90, 120, 150 and 180 min (A), as well as the AUC~0′--180′~ of prospective consumption (B), the ΔAUC~0′--180′~ of prospective consumption (C), the prospective consumption ~peak-0′~ (D), and the prospective consumption ~peak-nadir~ (E) in a mixed meal tolerance test.\
§*P* \< 0.05 compared to 180 min.](peerj-05-3090-g006){#fig-6}

The correlations between ABCD score and consumption behaviors
-------------------------------------------------------------

In the GB group, the duration of T2D before surgery was negatively correlated with the post-operative consumed time during the MMTT (*ρ* =  − 0.617, *P* = 0.0105). The other parameters of ABCD score was not correlated with any consumption behavior.

In the SG group, there was no any correlation between any parameter of ABCD score and any consumption behavior.

The correlations between ABCD score and appetite sensations
-----------------------------------------------------------

### The correlations between the age or duration of T2D before surgery with appetite sensations

In the GB group, there was no any correlation between the age or duration of T2D before surgery, with any appetite sensations.

In the SG group, the age was negative correlated with the post-operative ΔAUC~0′--180′~ of the desire to eat rating (*ρ* =  − 0.569, *P* = 0.021), and the post-operative fasting satiation rating (*ρ* =  − 0.554, *P* = 0.026). In addition, the duration of T2D before surgery was positively correlated with the post-operative fasting satiation rating (*ρ* = 0.501, *P* = 0.048).

### The correlations between BMI and appetite sensations

In the GB group, post-operative BMI was negatively correlated with the desire to eat rating for ~peak-0′~, while the ΔBMI was negatively correlated with post-operative fasting VAS scores for prospective consumption one year after surgery ([Figs. 7A](#fig-7){ref-type="fig"}--[7B](#fig-7){ref-type="fig"}).

In the SG group, post-operative BMI was positively correlated with the post-operative fasting score for hunger one year after surgery, and negatively correlated with the prospective consumption rating for ~peak-0′~ ([Figs. 7C](#fig-7){ref-type="fig"}--[7D](#fig-7){ref-type="fig"}). The ΔBMI was negatively correlated with the post-operative ΔAUC~0′--180′~ of the desire to eat rating, the post-operative fasting score for satiation, and the post-operative ΔAUC~0′--180′~ of the prospective consumption ([Figs. 7E](#fig-7){ref-type="fig"}--[7G](#fig-7){ref-type="fig"}).

![The relationships between post-operative BMI or ΔBMI with various visual analogue scale scores of appetite sensations in the gastric bypass (A, B) and sleeve gastrectomy (C--G) group.](peerj-05-3090-g007){#fig-7}

![The relationships between post-operative C-peptide levels with various visual analogue scale scores of appetite sensations in the gastric bypass (A--D) and sleeve gastrectomy (E--G) group.](peerj-05-3090-g008){#fig-8}

### The correlations between C-peptide levels and appetite sensations

In the GB group, post-operative C-peptide levels were negatively correlated with the ΔAUC~0′--180′~ of the hunger rating, the hunger rating for ~peak-0′~, ΔAUC~0′--180′~ of the desire to eat, and the desire to eat rating for ~peak-0′~ ([Figs. 8A](#fig-8){ref-type="fig"}--[8D](#fig-8){ref-type="fig"}).

In the SG patients, post-operative C-peptide levels were negatively correlated with the hunger rating for ~peak-0′~, ΔAUC~0′--180′~ of the fullness rating and the fullness rating score for ~peak-0′~ ([Figs. 8G](#fig-8){ref-type="fig"}--[8H](#fig-8){ref-type="fig"}).

Discussion
==========

Bariatric surgery is a promising method for the treatment of obesity by maintaining long-term weight loss, improving risk factors, and decreasing overall mortality ([@ref-34]). After bariatric surgery, patients have lower energy intake and higher physical activity levels than obese patients without surgery ([@ref-35]). These changes might be attributed to modified eating behavior ([@ref-31]; [@ref-23]) or bariatric surgical procedures ([@ref-32]).

VAS scores for appetite are significantly attenuated after GB and SG ([@ref-20]), and the volume of consumed food is consistently decreased after bariatric surgery ([@ref-24]). Patients who underwent GB had decreased AUC~0′--180′~ of the scores for hunger sensation ([@ref-5]; [@ref-38]) and increased AUC~0′--180′~ of the scores for satiety sensation ([@ref-21]; [@ref-5]; [@ref-38]) as compared with obese patients who did not undergo surgery or with the preoperative condition. GB patients also had a greater increase in satiety sensations than gastric banding patients ([@ref-22]). In SG patients, satiety sensation was increased ([@ref-38]), but the results for hunger sensation were inconsistent ([@ref-16]; [@ref-38]). Our previous study showed no significant difference in appetite sensation between patients treated with SG and those who underwent duodenal-jejunal bypass with SG ([@ref-40]).

In this study, we compared the consumption behaviors and appetite sensations of GB and SG patients one year after surgery. The ratio of BMI after/before surgery had no significant difference between GB and SG, which is comparable with our previous study ([@ref-26]). The effect of GB on BMI is similar to that of SG. Interestingly, T2D patients after GB had a decreasing trend of length of time of food consumption compared to those after SG. Because ABCD score is a validated, simple multidimensional grading system to predict successful diabetes remission after GB ([@ref-28]) and SG ([@ref-25]), our further analysis revealed that the duration of T2D was negatively correlated with the post-operative consumed time during the MMTT in the GB but not in the SG group. This novel finding highlights the importance of the duration of T2D in determining consumption behaviors after GB, in addition to its prediction value in diabetes remission.

Patients who underwent GB had significantly higher fasting scores for fullness and desire to eat, higher AUC~0′--180′~ of desire to eat, as well as more effective post-meal suppression of hunger and desire to eat compared with those undergoing SG one year after surgery. Taken together, T2D patients after GB might initially have a higher desire to eat with an opposing pre-meal fullness, as well as more significant post-meal suppression of hunger at 30 min and desire to eat at 30 and 60 min during the MMTT compared with those after SG, resulting in a trend toward a shorter length of time of food consumption in patients receiving GB one year after surgery. These differences in appetite sensations between T2D patients after either GB or SG may result from the different surgical procedures. Further studies are required for a detailed explanation of this interesting phenomenon.

T2D remission rates of 93% and 47% can be achieved in GB and SG patients, respectively, one year after surgery ([@ref-27]). Diabetes remission corresponds with the significantly decreased homeostasis model of assessment-insulin resistance and C-peptide levels in obese patients with T2D after bariatric surgery ([@ref-28]; [@ref-9]). C-peptide is considered as a marker for pancreatic insulin secretion ([@ref-4]; [@ref-18]), and it is typically used as an index of beta-cell function ([@ref-2]). C-peptide is also one part of the ABCD score, which predicts the success of bariatric surgery for diabetes remission ([@ref-28]). Previous studies have been shown that insulin in the brain suppresses food intake in rats ([@ref-11]), and intranasal insulin administration reduces the human brain activity stimulated by pictures of food ([@ref-13]), intensifies satiety and reduces the intake of palatable snacks in women ([@ref-14]), and enhances postprandial thermogenesis in healthy men ([@ref-1]). In addition, incremental increases in the AUC for plasma insulin during an oral glucose tolerance test have been shown to predict lower food intake, lower carbohydrate consumption, and reduced weight gain in healthy Pima Indians ([@ref-15]). Collectively, the evidence indicates a role for insulin as a negative feedback signal in the regulation of energy intake and body weight. In our current study, post-operative C-peptide levels in patients after GB were negatively correlated with hunger and desire to eat. Moreover, post-operative C-peptide levels in the SG group were negatively correlated with hunger and fullness.

Lastly, a pleiotropic endocrine response and newly established jejunal nutrient-sensing may contribute to appetite reduction, as well as to long-term improvement in body weight and glycemic control after bariatric surgery. Altered secretions of gut hormones caused by anatomic rearrangement of the gastrointestinal tract after bariatric surgery have been proposed as one of the mechanisms underlying this phenomenon ([@ref-7]; [@ref-8]; [@ref-26]; [@ref-37]). Recently, alteration of gut nutrient-sensing has been considered a potential therapeutic strategy to improve insulin sensitivity and glycemic control in diabetic rats after surgery ([@ref-6]; [@ref-30]). Collective evidence with our current results corroborates the concept that eating center controlling the consumption behaviors and appetite sensations is structured in a complex manner in the brain. However, these mechanisms require further investigation.

Conclusions
===========

In summary, T2D patients after either GB or SG exhibit distinct nutrient-induced consumption behaviors and appetite sensations post-operatively, which may account for the differential effects on weight loss and glycemic control after different surgery. Post-operative C-peptide levels have differential correlations with various appetite sensations in T2D patients after either GB or SG.
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